Portage Biotech Company Top Insiders

PRTG Stock  USD 4.31  0.29  6.30%   
Portage Biotech employs about 7 people. The company is managed by 12 executives with a total tenure of roughly 17 years, averaging almost 1.0 years of service per executive, having 0.58 employees per reported executive. Examination of Portage Biotech's management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Portage Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.

Portage Biotech's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Portage Biotech's future performance. Based on our forecasts, it is anticipated that Portage will maintain a workforce of roughly 10000 employees by March 2025.
 
Covid

Portage Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.1545) % which means that it has lost $0.1545 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9889) %, meaning that it created substantial loss on money invested by shareholders. Portage Biotech's management efficiency ratios could be used to measure how well Portage Biotech manages its routine affairs as well as how well it operates its assets and liabilities. The Portage Biotech's current Return On Tangible Assets is estimated to increase to -8.28. The current Return On Capital Employed is estimated to decrease to -3.52. The Portage Biotech's current Other Current Assets is estimated to increase to about 3.2 M, while Total Assets are projected to decrease to roughly 8.5 M.
The Portage Biotech's current Common Stock Shares Outstanding is estimated to increase to about 24.6 M, while Net Loss is forecasted to increase to (14.4 M).

Portage Biotech Workforce Comparison

Portage Biotech is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 3,241. Portage Biotech adds roughly 7.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Portage Biotech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Portage Biotech Price Series Summation is a cross summation of Portage Biotech price series and its benchmark/peer.

Portage Biotech Notable Stakeholders

A Portage Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Portage Biotech often face trade-offs trying to please all of them. Portage Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Portage Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Portage Biotech Management Performance

The success or failure of an entity such as Portage Biotech often depends on how effective the management is. Portage Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Portage management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Portage management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(8.72)(8.28)
Return On Capital Employed(3.35)(3.52)
Return On Assets(8.72)(8.28)
Return On Equity(16.86)(17.70)

Portage Biotech Workforce Analysis

Traditionally, organizations such as Portage Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Portage Biotech within its industry.

Portage Biotech Manpower Efficiency

Return on Portage Biotech Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee10.8M
Net Loss Per Executive6.3M
Working Capital Per Employee688K
Working Capital Per Executive401.3K

Complementary Tools for Portage Stock analysis

When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments